Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, et al.
2010-05-29 • Lancet
2010-05-29 • Lancet
Despite policies, strategies, and guidelines, the epidemic of HIV-associated tuberculosis continues to rage, particularly in southern Africa. We focus our attention on the regions with t...
Kavanagh M, Cohn J, Mabote L, Meier BM, Williams BG, et al.
2015-06-11 • Health and Human Rights Journal
2015-06-11 • Health and Human Rights Journal
Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people...
Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, et al.
2018-07-11 • PLOS Medicine
2018-07-11 • PLOS Medicine
An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optima...
Hill P, Dye C, Viney K, Tabutoa K, Kienene T, et al.
2014-08-01 • International Journal of Tuberculosis and Lung Disease
2014-08-01 • International Journal of Tuberculosis and Lung Disease
SETTING The global target of tuberculosis (TB) elimination by 2050 requires new approaches. Active case finding plus mass prophylactic treatment has been disappointing. We consider m...
